Lower extremity ulcers in connective tissue disease

Israel Medical Association Journal

Volumn 10, Issue 7, 2008, Pages 534-536

  Shanmugam, Victoria K ^a   Steen, Virginia D ^a   Cupps, Thomas R ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Atrophie blanche, lower extremity ulcer; Connective tissue disease, livedoid vasculopathy

Indexed keywords

ACETYLSALICYLIC ACID; BERAPROST; HEPARIN; PHOSPHOLIPID ANTIBODY; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD VESSEL INJURY; CONNECTIVE TISSUE DISEASE; HEALING IMPAIRMENT; HUMAN; LEG ULCER; PATHOGENESIS; THROMBOSIS; TISSUE INJURY; VASCULAR DISEASE; VASCULITIS; IMMUNOLOGY; REVIEW; RISK FACTOR; SKIN BLOOD VESSEL DISORDER;

ANTIBODIES, ANTIPHOSPHOLIPID; CONNECTIVE TISSUE DISEASES; HUMANS; LEG ULCER; RISK FACTORS; SKIN DISEASES, VASCULAR; VASCULITIS;

EID: 52049085599     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Goslen JB. Autoimmune ulceration of the leg. Clin Dermatol 1990; 8(3-4):92-117.
2. Thurtle OA, Cawley MI. The frequency of leg ulceration in rheumatoid arthritis: a survey. J Rheumatol 1983;10(3):507-9.
3. Tuffaneilli DL, Dubois EL. Cutaneous manifestations of systemic lupus erythematosus. Arch Dermatol 1964;90:377-86.
4. Callen JP. Livedoid vasculopathy: what it is and how the patient should be evaluated and treated. Arch Dermatol 2006;142(11):1481-2.
5. Hafner J, Schneider E, Burg G, Cassina PC. Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: the importance of concomitant arterial and venous disease. J Vasc Surg 2001;32(2):322-9.
6. Pun YL, Barraclough DR, Muirden KD. Leg ulcers in rheumatoid arthritis. Med J Aust 1990;153(10):585-7.
7. Youssef P, Brama T, Englert H, Bertouch J. Limited scleroderma is associated with increased prevalence of macrovascular disease. J Rheumatol 1995;22(3):469-72.
8. Thurtle O, Cawley M. The frequency of leg ulceration in rheumatoid arthritis: a survey. J Rheumatol 1983;10(3):507-9.
9. Acland KM, Darvay A, Wakelin SH, Russell-Jones R. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome? Br J Dermatol 1999;140(1):131-5.
10. Wakelin SH, Ellis JP, Black MM. Livedoid vasculitis with anticardiolipin antibodies: improvement with danazol. Br J Dermatol 1998; 139(5):935-7.
11. Hairston BR, Davis M, Pittelkow MR, Ahmed I. Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol 2006;142(11):1413-18.
12. Reyes E, Alarcon-Segovia D. Leg ulcers in the primary antiphospholipid syndrome. Report of a case with a peculiar proliferative small vessel vasculopathy. Clin Exp Rheumatol 1991;9(1):63-6.
13. Koike T, Bohagaki M, Amengual O, Atsumi T. Antiphospholipid antibodies: lessons from the bench. J Autoimmunity 2007;28:129-33.
14. Milstone LM, Braverman IM, Lucky P, Fleckman P. Classification and therapy of atrophie blanche. Arch Dermatol 1983;119(12):963-9.
15. Miura T, Torinuki W. Clinical course of atrophie blanche. J Dermatol 1977;4(6):259-62.
16. McCalmont CS, McCalmont TH, Jorizzo JL, White WL, Leshin B, Rothberger H. Livedo vasculitis: vasculitis or thrombotic vasculopathy? Clin Exp Dermatol 1992;17(1):4-8.
17. Pizzo SV, Murray JC, Gonias SL. Atrophie blanche. A disorder associated with defective release of tissue plasminogen activator. Arch Pathol Lab Med 1986;110(6):517-19.
18. Klein KL, Pittelkow MR. Tissue plasminogen activator for treatment of livedoid vasculitis. Mayo Clinic Proc 1992;67(10):923-33.
19. Deng A, Gocke CD, Hess J, Heyman M, Paltiel M, Gaspari A. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator. Arch Dermatol 2006;142(11):1466-9.
20. Tsutsui K, Shirasaki F, Takata M, Takehara K. Successful treatment of livedo vasculitis with beraprost sodium: a possible mechanism of thrombomodulin upregulation. Dermatology 1996;192(2):120-4.
21. Jetton RL, Lazarus GS. Minidose heparin therapy for vasculitis of atrophie blanche. J Am Acad Dermatol 1983;8(1):23-6.
22. Heine KG, Davis GW. Idiopathic atrophie blanche: treatment with low-dose heparin. Arch Dermatol 1986;122(8):855-6.
23. Hairston BR, Davis MDP, Gibson LE, Drage LA. Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases. Arch Dermatol 2003;139(8):987-90.